Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty.

D'Lima DD, Venn-Watson EJ, Tripuraneni P, Colwell CW.

Orthopedics. 2001 Dec;24(12):1139-43.

PMID:
11770090
2.
3.

No effective prophylaxis of heterotopic ossification with short-term ibuprofen.

Koorevaar CT, Hu HP, Lemmens A, van Kampen A.

Arch Orthop Trauma Surg. 1999;119(3-4):183-5.

PMID:
10392515
4.

Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.

Seegenschmiedt MH, Keilholz L, Martus P, Goldmann A, Wölfel R, Henning F, Sauer R.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):161-71.

PMID:
9300751
5.

Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.

Dorn U, Grethen C, Effenberger H, Berka H, Ramsauer T, Drekonja T.

Acta Orthop Scand. 1998 Apr;69(2):107-10.

PMID:
9602763
6.

[Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].

Sauer R, Seegenschmiedt MH, Goldmann A, Beck H, Andreas P.

Strahlenther Onkol. 1992 Feb;168(2):89-99. German.

PMID:
1542851
7.

Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.

Amstutz HC, Fowble VA, Schmalzried TP, Dorey FJ.

J Arthroplasty. 1997 Feb;12(2):126-32.

PMID:
9139094
8.

Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.

Romanò CL, Duci D, Romanò D, Mazza M, Meani E.

J Arthroplasty. 2004 Jan;19(1):14-8.

PMID:
14716644
9.
11.

Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.

Koelbl O, Seufert J, Pohl F, Tauscher A, Lehmann H, Springorum HW, Flentje M.

Strahlenther Onkol. 2003 Nov;179(11):767-73.

PMID:
14605747
12.

Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.

van der Heide HJ, Koorevaar RT, Schreurs BW, van Kampen A, Lemmens A.

J Arthroplasty. 1999 Oct;14(7):796-9.

PMID:
10537252
13.

[Radiotherapy as prevention of heterotopic ossification--preliminary results].

Miszczyk L, Spindel J, Maciejewski B, Walichiewicz P, Tarnawski R, Horzela A, Woźniak G.

Przegl Lek. 2004;61(2):61-4. Polish.

PMID:
15230142
14.

Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.

van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW.

Acta Orthop. 2007 Feb;78(1):90-4.

PMID:
17453398
15.

Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty.

Healy WL, Lo TC, Covall DJ, Pfeifer BA, Wasilewski SA.

J Arthroplasty. 1990 Dec;5(4):369-75.

PMID:
2127057
16.

The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study.

Sell S, Willms R, Jany R, Esenwein S, Gaissmaier C, Martini F, Bruhn G, Burkhardsmaier F, Bamberg M, Küsswetter W.

J Arthroplasty. 1998 Dec;13(8):854-9.

PMID:
9880175
17.

Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy.

Seegenschmiedt MH, Goldmann AR, Wölfel R, Hohmann D, Beck H, Sauer R.

Radiother Oncol. 1993 Mar;26(3):271-4. Review.

PMID:
8316658
18.

The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty.

Board TN, Karva A, Board RE, Gambhir AK, Porter ML.

J Bone Joint Surg Br. 2007 Apr;89(4):434-40. Review.

19.

Heterotopic ossification in patients after total hip replacement.

Stołtny T, Koczy B, Wawrzynek W, Miszczyk L.

Ortop Traumatol Rehabil. 2007 May-Jun;9(3):264-72. Review. English, Polish.

PMID:
17721424
20.

[Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].

Heyd R, Strassmann G, Kirchner J, Schopohl B, Böttcher HD.

Strahlenther Onkol. 1996 Oct;172(10):543-52. German.

PMID:
8966671

Supplemental Content

Support Center